Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11654184 Alkaline phosphatase agents for treatment of radiation disorders

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

May 23, 2023

0

Patent Application Number

169822110

Date Filed

March 20, 2019

0

Patent Citations

US Patent 7423029 Compounds to promote regeneration of bone marrow

0

US Patent 7501116 Placental alkaline phosphatase to control diabetes

0

US Patent 7557081 Alpha-1-acid glycoprotein for the treatment of diabetes

0

US Patent 7589083 Compounds and compositions to control abnormal cell growth

0

US Patent 7655620 Use of one or more metal carriers to selectively kill mammalian cells

0

US Patent 7695714 Use of alkaline phosphatase to maintain healthy tissue mass in mammals

0

US Patent 7763712 Bone delivery conjugates and method of using same to target proteins to bone

0

US Patent 7781423 Compounds to promote regeneration of bone marrow

0

...

Patent Primary Examiner

Ralph J Gitomer

0

The present invention relates to, inter alia, compositions and methods, including therapeutic alkaline phosphatases that find use in the treatment or prevention of the effects of radiation exposure and/or chemotherapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11654184 Alkaline phosphatase agents for treatment of radiation disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.